ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,948,748 | -7.2% | 503,330 | -33.9% | 0.05% | -21.0% |
| Q1 2023 | $19,333,134 | +73404.4% | 761,147 | +17.2% | 0.06% | -42.6% |
| Q4 2022 | $26,302 | -94.9% | 649,548 | +4031.7% | 0.11% | +5300.0% |
| Q3 2022 | $520,000 | -96.6% | 15,721 | -96.3% | 0.00% | -92.3% |
| Q2 2022 | $15,316,000 | +2103.7% | 425,842 | +2915.5% | 0.03% | +1200.0% |
| Q1 2022 | $695,000 | -93.2% | 14,122 | -90.8% | 0.00% | -92.3% |
| Q4 2021 | $10,244,000 | +17.3% | 154,298 | +10.5% | 0.03% | +18.2% |
| Q3 2021 | $8,730,000 | -40.3% | 139,628 | -20.7% | 0.02% | -40.5% |
| Q2 2021 | $14,611,000 | +326.5% | 176,050 | +241.3% | 0.04% | +362.5% |
| Q1 2021 | $3,426,000 | -82.0% | 51,588 | -79.3% | 0.01% | -75.0% |
| Q4 2020 | $19,075,000 | +4854.5% | 248,657 | +2678.3% | 0.03% | +3100.0% |
| Q3 2020 | $385,000 | -32.2% | 8,950 | -32.2% | 0.00% | -50.0% |
| Q2 2020 | $568,000 | -65.3% | 13,200 | -76.8% | 0.00% | -71.4% |
| Q1 2020 | $1,637,000 | – | 57,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |